Shot in the arm for Biota
Shares in the anti-influenza drug developer Biota Holdings have staged a rebound now that the bad news regarding the drop in royalty payments is out of the way.
Brendon Lau
Updated
Biota Holdings (BTA)
Shares in the anti-influenza drug developer have staged a rebound now that the bad news regarding the drop in royalty payments is out of the way.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Companies
Fetching latest articles